Health Care

Consumers losing doctors with Obamacare plans

May 13, 2014
Associated Press
Before the law took effect, experts warned that narrow networks could impact patient's access to care, especially in cheaper plans. But with insurance cards now in hand, consumers are finding their access limited across all price ranges.
More

Lilly to appeal $450M ruling over poisoned workers in Brazil

May 12, 2014
 IBJ Staff
Brazilian federal prosecutors had accused a Lilly subsidiary of incinerating toxic waste at the plant that it operated until 2003.
More

Lilly says its once-daily insulin tops competitor's drug

May 12, 2014
Bloomberg News
Eli Lilly & Co. said its experimental insulin helped diabetic patients more than Sanofi’s biggest product in studies that also raised some safety risks.
More

Not-for-profit focused on exercise adopts novel funding modelRestricted Content

May 10, 2014
Andrea Muirragui Davis
When Tom Hanley couldn’t get large charitable foundations to support a wellness program he developed for central Indiana youth, he switched gears and adopted a fee-for-service model underwritten largely by sponsorships.
More

UPDATE: Doctors nationwide victimized in ID theft fraud

May 9, 2014
Associated Press
The American Medical Association says the exact number of doctors affected by tax fraud isn't known, but hundreds of cases have been confirmed, including dozens in Indiana.
More

U.S. House votes to revive expired research tax credit

May 9, 2014
Bloomberg News
The 274-131 vote follows calls to restore the credit by a coalition of companies including Indianapolis-based Eli Lilly and Co. and Texas Instruments Inc.
More

Health insurers: Payment rates meeting expectations

May 7, 2014
Associated Press
Top health insurance companies told members of Congress Wednesday that more than 80 percent of people who've signed up under the president's new health care law have gone on to pay their premiums.
More

Bayer’s $14.2 billion Merck buy shows pharma strategy split

May 7, 2014
Bloomberg News
Bayer AG's $14.2 billion acquisition of Merck & Co. is the latest in a series of big pharma deals and it exposes a deepening split in the way drugmakers approach their portfolios.
More

Insurers say most Obamacare enrollees paying premiums

May 6, 2014
Bloomberg News
Three large health insurers including Indianapolis-based WellPoint Inc. and Aetna Inc. say that a high percentage of their new Obamacare customers are paying their first premiums, partly undermining a Republican criticism of enrollment in the program.
More

Veterans Affairs department rejects call for leader to quit

May 6, 2014
Associated Press
The Indianapolis-based American Legion, the nation's largest veterans service group, called Monday for the resignations of U.S. Veterans Affairs Secretary Eric Shinseki and two of his top aides amid an investigation into allegations of corruption and unnecessary deaths.
More

Zimmer-Biomet deal could stanch their bleeding at hospitals

May 5, 2014
J.K. Wall
Hospitals, which have forced orthopedic implant makers to lower their prices in recent years, may have a harder time doing so when the combined Zimmer-Biomet controls nearly 40 percent of the market.
More

Hospitals might limit executives' pay hikes after run of big increases

May 3, 2014
J.K. Wall
Before local hospitals slashed staff and expenses last year, they had been boosting the pay packages of their top executives faster than hospitals around the country. Seven of every 10 senior executives at the major hospital systems in Indianapolis saw their total compensation rise more than 10 percent from 2010 to 2012.
More

St. Vincent and Community to dissolve partnership

May 3, 2014
J.K. Wall
The Accountable Care Consortium was envisioned as a vehicle through which the hospitals would eventually funnel all of their roughly $2.5 billion in annual contracts with health insurers and employers.
More

Endocyte shares plunge 60 percent after drug trial is stopped

May 2, 2014
 Bloomberg News and IBJ Staff
Endocyte Inc.'s stock fell more than 60 percent in early trading Friday after the drug it’s developing with Merck & Co.’s backing failed to help patients in a trial for ovarian cancer.
More

Indiana signups lag for federal health care law

May 1, 2014
Associated Press
Data from the U.S. Department of Health and Human Services show that a total of nearly 230,000 Indiana residents were eligible to enroll in a marketplace plan, but only about 132,000 had done so by the March 31 deadline.
More

Drug prices surge as generics, niche treatments eat profit

May 1, 2014
Bloomberg News
Since 2007, the cost of brand-name medicines has jumped, with prices doubling for dozens of established drugs that target everything from multiple sclerosis to cancer, blood pressure and even erections, according to an analysis conducted for Bloomberg News.
More

CEOs launch childhood obesity initiative

April 30, 2014
J.K. Wall
Jump IN for Healthy Kids has a budget of $1.5 million and hopes to identify and extend successful efforts to improve diet, activity and healthy choices among children and their families.
More

Roche battles payment cuts while growing diagnostics business

April 28, 2014
J.K. Wall

Life Sciences Burris
                           interview Watch VideoNew tests have helped Roche Diagnostics grow its North American revenue, excluding its troubled diabetes care business, 23 percent over the past five years. But the money for diagnostic tests continues to go down in key areas, noted CFO Wayne Burris.

More

Lilly trade-secret defendants released to home detention

April 28, 2014
Bloomberg News
The court noted that after the government filed a second indictment March 12, the trade-secret theft claims against Guoqing Cao and Shuyu Li were changed to wire fraud, and aiding and abetting and conspiracy to commit wire fraud.
More

Hospitals rethinking a la carte pricingRestricted Content

April 26, 2014
J.K. Wall
Indianapolis hospitals have begun to offer joint replacement surgeries to employers and insurers using “bundled prices.” That means, instead of billing piecemeal for each individual service and supply, the hospitals wrap everything needed from just before to just after surgery into a package deal.
More

Novartis deal caps turnaround for ElancoRestricted Content

April 26, 2014
J.K. Wall
Next year, after Lilly completes its $5.4 billion acquisition of Novartis Animal Health, Elanco will contribute 17 percent of revenue—or one out of every six dollars flowing into Lilly’s coffers.
More

Zimmer buying Biomet in $13.3B deal between Hoosier firms

April 24, 2014
Bloomberg News, Associated Press
Orthopedic device maker Zimmer Holdings Inc. is buying privately-held competitor Biomet Inc. in a cash-and-stock deal between the Warsaw-based companies valued at about $13.35 billion.
More

Lilly's quarterly profit meets analyst expectations

April 24, 2014
Bloomberg News
The drugmaker, which is weathering patent expirations, saw sales fall more slowly than expected for its antidepressant Cymbalta.
More

Investor pressure pushing drugmakers to make deals

April 23, 2014
Associated Press
Tuesday's blockbuster deal involving Indianapolis-based Eli Lilly and Co. was just the latest of several that have taken place since the beginning of the year.
More

Three more charged in $80M heist of Lilly drugs

April 23, 2014
Associated Press
Three Florida men who federal authorities say stole about $80 million in prescription drugs from an Eli Lilly and Co. warehouse in Connecticut have been charged with conspiracy and theft.
More
Page  << 1 2 3 4 5 6 7 8 9 10 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. By Mr. Lee's own admission, he basically ran pro-bono ads on the billboard. Paying advertisers didn't want ads on a controversial, ugly billboard that turned off customers. At least one of Mr. Lee's free advertisers dropped out early because they found that Mr. Lee's advertising was having negative impact. So Mr. Lee is disingenous to say the city now owes him for lost revenue. Mr. Lee quickly realized his monstrosity had a dim future and is trying to get the city to bail him out. And that's why the billboard came down so quickly.

  2. Merchants Square is back. The small strip center to the south of 116th is 100% leased, McAlister’s is doing well in the outlot building. The former O’Charleys is leased but is going through permitting with the State and the town of Carmel. Mac Grill is closing all of their Indy locations (not just Merchants) and this will allow for a new restaurant concept to backfill both of their locations. As for the north side of 116th a new dinner movie theater and brewery is under construction to fill most of the vacancy left by Hobby Lobby and Old Navy.

  3. Yes it does have an ethics commission which enforce the law which prohibits 12 specific items. google it

  4. Thanks for reading and replying. If you want to see the differentiation for research, speaking and consulting, check out the spreadsheet I linked to at the bottom of the post; it is broken out exactly that way. I can only include so much detail in a blog post before it becomes something other than a blog post.

  5. 1. There is no allegation of corruption, Marty, to imply otherwise if false. 2. Is the "State Rule" a law? I suspect not. 3. Is Mr. Woodruff obligated via an employment agreement (contractual obligation) to not work with the engineering firm? 4. In many states a right to earn a living will trump non-competes and other contractual obligations, does Mr. Woodruff's personal right to earn a living trump any contractual obligations that might or might not be out there. 5. Lawyers in state government routinely go work for law firms they were formally working with in their regulatory actions. You can see a steady stream to firms like B&D from state government. It would be interesting for IBJ to do a review of current lawyers and find out how their past decisions affected the law firms clients. Since there is a buffer between regulated company and the regulator working for a law firm technically is not in violation of ethics but you have to wonder if decisions were made in favor of certain firms and quid pro quo jobs resulted. Start with the DOI in this review. Very interesting.

ADVERTISEMENT